MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,056,912 | +2.8% | 195,320 | +5.7% | 0.04% | -2.4% |
| Q1 2023 | $6,867,741 | +260.7% | 184,716 | +339.6% | 0.04% | +223.1% |
| Q4 2022 | $1,904,017 | +847.3% | 42,022 | +4497.6% | 0.01% | +550.0% |
| Q4 2020 | $201,000 | -82.7% | 914 | -96.1% | 0.00% | -88.9% |
| Q2 2018 | $1,159,000 | +60.7% | 23,500 | 0.0% | 0.02% | +50.0% |
| Q1 2018 | $721,000 | +38.7% | 23,500 | -17.5% | 0.01% | +33.3% |
| Q4 2017 | $520,000 | +89.1% | 28,500 | +21.3% | 0.01% | +80.0% |
| Q3 2017 | $275,000 | +570.7% | 23,500 | +109.8% | 0.01% | +400.0% |
| Q2 2017 | $41,000 | – | 11,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |